Literature DB >> 7081722

[Treatment with immunoglobulins in poor risk patients. A contribution to early re-laparotomy (author's transl)].

P Eckert, M Barbey-Schneider, R Schneider, W Sauerwein.   

Abstract

In a first period of two years the total number of patients with re-laparotomy was 1.7 per cent (41/2412). The death rate in these cases was 48.8 per cent. In a second period of nine months we found a re-laparotomy rate of 0.69 per cent (7/1022). The death rate of these seven cases with re-laparotomy amounted to 14.3 per cent. All together in the second period the number of re-laparotomies decreased evidently and the postoperative course was less complicated. The experience with the patients who died in the first period was a reason to classify the cases in a group with particular risk. For this reason the endangered patients were operated in the second period by the same surgeon. The medication and intensive care were the same, but we instilled ten g of a immune globulin into the abdominal cavity of these endangered patients. The reasons and the indication of this therapy will be discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7081722

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  3 in total

1.  [Immunoglobulins in the treatment of bacterial meningitis in childhood].

Authors:  R Noack; C Szugs; H Scholz
Journal:  Infection       Date:  1987 Jan-Feb       Impact factor: 3.553

2.  [Nitroblue tetrazolium (NBT) test as a potential diagnostic aid in the preoperative detection of patients at risk for infection].

Authors:  F Schulz; G Laber; T Rath
Journal:  Langenbecks Arch Chir       Date:  1985

3.  [Effect of adjuvant immunoglobulin therapy on infections in patients in an surgical intensive care unit. Results of a randomized controlled study].

Authors:  H M Just; M Metzger; W Vogel; R B Pelka
Journal:  Klin Wochenschr       Date:  1986-03-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.